Table 2 Outcomes regarding feasibility, prevalence, accuracy parameters, and time to measurement of included studies
Study | Feasibility | Prevalence of pneumothorax (%) | Prevalence of malposition (%) | Specificity (95% CI)1 | Sensitivity (95% CI)2 | Mean time for US (min) (±SD)4 [IQR] | Mean time for CXR performance (min) (±SD)4 [IQR] | Mean time for CXR interpretation (min) (±SD)4 [IQR] |
|---|---|---|---|---|---|---|---|---|
Killu et al. (2010) [47] | 100% | – | 0% | 100.0 (47.8–100) | – | 4.2 | – | – |
Kim et al. (2015) [26] | 92% | – | 0% | 100 (92.0–100) | – | 11 (0.72) | 111 (31) | – |
Kim et al. (2016) [25] | 100% | – | 0% | 100 (81.5–100) | – | – | – | – |
Baviskar et al. (2015) [48] | 100% | – | 0% | 100 (86.3–100) | – | 0.75 (0.25) | – | – |
Cortellaro et al. (2014) [49] | 100% | – | 8.4% | 98.5 (91.7–100) | 33.3 (4.3–77.7) | 4 (1) | – | 288 (216) |
Duran-Gehring et al. (2015) [50] | 92% | 4.3% | 6.5% | 100 (91.8–100) | 33.3 (0.8–90.6) | 5 (0.8) | 28.2 (11.3) | 299 (90.5) |
Gekle et al. (2015) [51] | 100% | 0% | 0% | 100 (94.7–100) | – | 8.80 (1.34) | 45.78 (8.75) | |
Kamalipour et al. (2016) [52] | 89.7% | – | 15.4% | 97.7 (92.0–99.7) | 68.8 (41.0–89.0) | – | – | – |
Lanza et al. (2006) [53] | 100% | 0.9% | 11.2% | 100 (96.2–100) | 83.3 (51.0–97.7) | – | – | – |
Salimi et al.* (2015) [17] | 100% | – | 30.5% | 91.2 (80.7–97.1) | 28.0 (12.1–49.4) | – | – | – |
Santarsia et al. (2000) [54] | 100% | – | 1.9% | 100 (93.3–100) | 100 (2.5–100) | – | – | – |
Weekes et al. (2014) [55] | 96.6% | – | 2.7% | 100 (97.5–100) | 75.0 (19.4–99.4) | – | – | – |
Weekes et al. (2016) [56] | 97.4% | – | 2.6% | 100 (97.5–100) | 75.0 (19.4–99.4) | 1.1 (0.7) | 20 (30) | – |
Wen et al. (2014) [57] | 100% | – | 0.9% | 100 (98.3–100) | 100 (15.8–100) | 3.2 (1.1) | 28.3 (25.7) | – |
Alonso-Quintela et al. (2015) [58] | 100% | – | 11.8% | 95.6 (84.9–99.5) | 100 (54.1–100) | 2.23 (1.06) | – | 22.96 (20.43) |
Maury et al. (2001) [59] | 98.8% | 1.2% | 10.7% | 100 (95.2–100) | 100 (66.4–100) | 6.8 (3.5) | 80.3 (66.7) | – |
Miccini et al. (2016) [46] | 100% | 1.0% | 1.3% | 100 (98.8–100) | 100 (39.8–100) | – | – | – |
Park et al. (2014) [60] | 96.2% | – | 0% | 100 (96.4–100) | – | – | – | – |
Arellano et al. (2014) [27] | 94% | – | 0% | 96.8 (91.0–99.3) | – | – | – | – |
Bedel et al. (2013) [24] | 97% | 0% | 6.2% | 100 (96.0–100) | 83.3 (35.9–99.6) | 1.76 (1.3) | 49 (31) | 103 (81) |
Blans et al. (2016) [18] | 98.1% | 0% | 5.8% | 98.0 (89.4–99.9) | 0 (0–70.8) | – | – | 24.5 [18.1–45.3] |
Matsushima and Frankel (2010) [19] | 71% | 0% | 16.9% | 98.0 (89.4–99.9) | 50.0 (18.7–81.3) | 10.8 | – | 75.3 |
Meggiolaro et al. (2015) [32] | 100% | 0% | 13.3% | 100 (96.0–100) | 64.3 (35.1–87.2) | 5.0 [5.0-10.0] | – | 67.0 [42.0–84.0] |
Vezzani et al. (2010) [31] | 89.2% | 1.8% | 28.3% | 95.8 (88.1–99.1) | 92.9 (76.5–99.1) | 10 (5) | 83 (79) | – |
Zanobetti et al. (2013) [61] | 100% | 2.0% | 4.4% | 100 (98.1–100) | 55.6 (21.2–86.3) | 5 (3) | – | 65 (74) |
Pooled (patients, n) | (patients, n = 1267) | (patients, n = 2548) | (patients, n = 1362) | (patients, n = 749) | (patients, n = 777) | |||
All studies (2548) | 96.8% | 1.1% | 6.8% | 98.4 (97.8–99.5) | 68.2 (54.4–79.4) | 2.83 (95% CI: 2.77–2.89) | 34.7 (95% CI: 32.6–36.7) | 46.3 (95% CI: 44.4–48.2) |
Supraclavicular ultrasound (76) | 94.6% | – | 0% | 100 (94.4–100)3 | – | |||
TTE and CEUS (1195) | 97.7% | 1.4% | 6.8% | 98.9 (96.1–99.7) | 68.7 (61.7–96.4) | |||
Vascular ultrasound and TTE (729) | 98.1% | 0.8% | 3.4% | 99.0 (96.5–99.7) | 96.1 (79.7–99.4) | |||
Vascular ultrasound, TTE and CEUS (548) | 93.3% | 1.4% | 12.3% | 98.6 (96.1–99.5) | 56.2 (32.8–77.1) |